BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29360079)

  • 1. [4pp Mucocutaneous manifestations of methotrexate toxicity].
    Ferrari B; Kogan N; Veira RC; Luna PC; Larralde M; Cuesta MG; Díaz P; Rossi MV; Aloise I
    Medicina (B Aires); 2018; 78(1):50-53. PubMed ID: 29360079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
    Berna R; Rosenbach M; Margolis DJ; Mitra N; Baumrin E
    Am J Clin Dermatol; 2022 Jul; 23(4):449-457. PubMed ID: 35486323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acral erosions and ulcers: an early sign of severe acute methotrexate toxicity.
    Maroñas-Jiménez L; Castellanos-González M; Sanz Bueno J; Vanaclocha Sebastián F
    Actas Dermosifiliogr; 2014 Apr; 105(3):322-3. PubMed ID: 24657026
    [No Abstract]   [Full Text] [Related]  

  • 5. Ulcerations due to methotrexate toxicity in a psoriasis patient.
    Souza CF; Suarez OM; Silva TF; Gorenstein AC; Quintella LP; Avelleira JC
    An Bras Dermatol; 2016; 91(3):375-7. PubMed ID: 27438211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
    Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
    Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
    Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
    Delyon J; Ortonne N; Benayoun E; Moroch J; Wolkenstein P; Sbidian E; Chosidow O
    J Am Acad Dermatol; 2015 Sep; 73(3):484-90. PubMed ID: 26190242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eventration and methotrexate in psoriasis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous ulceration as a sign of methotrexate toxicity.
    Del Pozo J; Martínez W; García-Silva J; Almagro M; Peña-Penabad C; Fonseca E
    Eur J Dermatol; 2001; 11(5):450-2. PubMed ID: 11525955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
    Ferguson NN; Asarch A; VanBeek M; Swick BL
    Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
    Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
    Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate toxicity presenting as ulceration of psoriatic plaques: a report of two cases.
    Agarwal KK; Nath AK; Thappa DM
    Indian J Dermatol Venereol Leprol; 2008; 74(5):481-4. PubMed ID: 19052409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucocutaneous ulcerations secondary to methotrexate.
    Warner J; Brown A; Whitmore SE; Cowan DA
    Cutis; 2008 May; 81(5):413-6. PubMed ID: 18543592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
    Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
    Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erosion of psoriatic plaques: an early sign of methotrexate toxicity.
    Pearce HP; Wilson BB
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 2):835-8. PubMed ID: 8912599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic EBV-Positive Methotrexate-Related Lymphoproliferative Disorder Associated With Skin Lesion Resembling EBV-Positive Mucocutaneous Ulcer: A Report of Two Cases.
    Fujimoto M; Takai T; Okada M; Okuno A; Haga H
    Am J Dermatopathol; 2021 Aug; 43(8):604-605. PubMed ID: 33606374
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate-Induced Cutaneous Erosions.
    Mönch S; Zimmo B; El Helou T; Colmegna I
    Arthritis Rheumatol; 2016 Jan; 68(1):254. PubMed ID: 26314707
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature.
    Kurian A; Haber R
    J Cutan Med Surg; 2011; 15(5):275-9. PubMed ID: 21962187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate toxicity presenting as ulcerated psoriatic plaques.
    Wong SM; Chong YT; Thevarajah S; Baba R
    Australas J Dermatol; 2012 Feb; 53(1):81-3. PubMed ID: 22309341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.